BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 17472045)

  • 41. [Disseminated zygomycosis in a patient with chronic lymphocytic leukemia].
    Sanz-Bueno J; Castellanos-González M; Rodríguez-Peralto JL; Rivera R
    Med Clin (Barc); 2013 Jun; 140(11):e21. PubMed ID: 23537740
    [No Abstract]   [Full Text] [Related]  

  • 42. Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient - Case report and review of literature.
    Khatri A; Chang KM; Berlinrut I; Wallach F
    J Mycol Med; 2021 Jun; 31(2):101125. PubMed ID: 33857916
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonfatal gastric mucormycosis in a renal transplant recipient.
    Martinez EJ; Cancio MR; Sinnott JT; Vincent AL; Brantley SG
    South Med J; 1997 Mar; 90(3):341-4. PubMed ID: 9076311
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Case report of hepatic mucormycosis after liver transplantation: successful treatment with liposomal amphotericin B followed by posaconazole sequential therapy.
    Abboud CS; Bergamasco MD; Baía CE; Lallée MP; Zan AS; Zamorano MM; Pereira OI; Mies S
    Transplant Proc; 2012 Oct; 44(8):2501-2. PubMed ID: 23026630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model.
    Sun QN; Najvar LK; Bocanegra R; Loebenberg D; Graybill JR
    Antimicrob Agents Chemother; 2002 Jul; 46(7):2310-2. PubMed ID: 12069997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Mucormycosis: therapeutic news].
    Pilmis B; Lanternier F; Lortholary O
    Med Sci (Paris); 2013 Mar; 29 Spec No 1():25-30. PubMed ID: 23510522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Zygomycosis over-infection during voriconazole therapy for aspergillosis in a heart transplant patient, successfully treated with liposomal amphotericin and posaconazole.
    Bourke P; Castro P; Rabagliati R; Beltran C; Verdejo H; Winter JL; Bourge RC
    Transpl Infect Dis; 2012 Oct; 14(5):E56-9. PubMed ID: 22852999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cutaneous mucormycosis.
    Vulsteke JB; Deeren D
    Transpl Infect Dis; 2019 Apr; 21(2):e13039. PubMed ID: 30548761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
    Friese G; Discher T; Füssle R; Schmalreck A; Lohmeyer J
    AIDS; 2001 Nov; 15(17):2344-5. PubMed ID: 11698718
    [No Abstract]   [Full Text] [Related]  

  • 50. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
    Almyroudis NG; Sutton DA; Fothergill AW; Rinaldi MG; Kusne S
    Antimicrob Agents Chemother; 2007 Jul; 51(7):2587-90. PubMed ID: 17452481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Triple antifungal therapy for the treatment of invasive aspergillosis in a neutropenic pediatric patient.
    Sims-McCallum RP
    Am J Health Syst Pharm; 2003 Nov; 60(22):2352-6. PubMed ID: 14652986
    [No Abstract]   [Full Text] [Related]  

  • 52. Rare lower extremity invasive fungal infection in an immunosuppressed patient: Exserohilum longirostratum.
    Al-Attar A; Williams CG; Redett RJ
    Plast Reconstr Surg; 2006 Mar; 117(3):44e-47e. PubMed ID: 16525254
    [No Abstract]   [Full Text] [Related]  

  • 53. Successful cure of an extensive burn injury complicated with mucor wound sepsis.
    Tang D; Wang W
    Burns; 1998 Feb; 24(1):72-3. PubMed ID: 9601596
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug combinations against Mucor irregularis in vitro.
    Zhang S; Li R; Yu J
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3395-7. PubMed ID: 23587956
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Primary cutaneous mucormycosis. Report of a case in a HIV patient].
    Pérez-Uribe A; Molina de Soschin D; Arenas R; Reyes M
    Rev Iberoam Micol; 2005 Jun; 22(2):118-21. PubMed ID: 16107172
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Rare Case of Pulmonary Coinfection by Lichtheimia ramosa and Aspergillus fumigatus in a Patient With Delayed Graft Function After Renal Transplantation.
    Zhang Q; Liu H; Qiu S; Wang W; Yang L; Chen H; Chen X; Shen Z
    Transplant Proc; 2019 Mar; 51(2):551-555. PubMed ID: 30879588
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Surgical-site mucormycosis infection in a solid-organ transplant recipient and a concise review of the literature.
    Haque H; Nettboy S; Kumar S
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31826901
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Successful treatment of mucormycosis after kidney transplantation.
    Miladipour A; Ghanei E; Nasrollahi A; Moghaddasi H
    Iran J Kidney Dis; 2008 Jul; 2(3):163-6. PubMed ID: 19377232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unclear fever 7 weeks after renal transplantation in a 56-year-old patient.
    Guetgemann A; Brandenburg VM; Ketteler M; Riehl J; Floege J
    Nephrol Dial Transplant; 2006 Aug; 21(8):2325-7. PubMed ID: 16751654
    [No Abstract]   [Full Text] [Related]  

  • 60. Treatment of invasive infections due to rare or emerging yeasts and moulds.
    Sahin GO; Akova M
    Expert Opin Pharmacother; 2006 Jun; 7(9):1181-90. PubMed ID: 16732704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.